FDA
-
-
-
-
-
-
-
Eloxx doses first patients in Phase 2b Alport syndrome trial
-
-
-
-
-
-
-
Canaccord Starts Bubs Australia Ltd (BUB:AU) at Spec. Buy
-
-
-
-
-
-
-
Shoulder Innovations wins FDA clearance for titanium shoulder implant
-
-
-
-
-
-
-
Candel Therapeutics adds regulatory veteran to its board
-
-
-
-
-
-
-
Labcorp sets long-term growth targets at investor day
-
-
-
-
-
-
-
FDA grants Bayer's HYRNUO accelerated approval as first-line NSCLC therapy
-
-
-
-
-
-
-
ENvue Medical resumes U.S. shipments of PainShield device
-
330,741 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

